Eser, M., Kement, M., Balin, S., Coskun, C., Kefeli, U., Gumus, M., . . . Mayadagli, A. (2012). Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer. BioMed Central.
Citação norma ChicagoEser, Mehmet, Metin Kement, Salim Balin, Cihan Coskun, Umut Kefeli, Mahmut Gumus, Yunus Emre Altuntas, Necmi Kurt, and Alparslan Mayadagli. Is There Any Role of Thrombin Activatable Fibrinolysis Inhibitor in the Development of a Hypercoagulable State in Gastric Cancer. BioMed Central, 2012.
MLA citiranjeEser, Mehmet, et al. Is There Any Role of Thrombin Activatable Fibrinolysis Inhibitor in the Development of a Hypercoagulable State in Gastric Cancer. BioMed Central, 2012.
Opozorilo: Ti citati niso vedno 100% točni.